Incannex Healthcare (IXHL) Non Operating Income (2022 - 2026)
Incannex Healthcare (IXHL) posted Non Operating Income of $165000.0 for Q1 2026, down 65.19% sequentially from $474000.0 in Q4 2025, and down 84.06% YoY from $1.0 million in Q1 2025.
Incannex Healthcare (IXHL) Non Operating Income (2022 - 2026) Analysis & Trends
Incannex Healthcare has reported Non Operating Income for 5 years, with the latest figure at $165000.0 in Q1 2026.
- Quarterly Non Operating Income fell 84.06% year-over-year to $165000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$23.0 million (down 637.02% YoY) and the FY2025 annual result came in at -$23.1 million, down 298.9% from the prior year.
- Non Operating Income retreated to $165000.0 in Q1 2026 per IXHL's latest filing, from $474000.0 in the prior quarter.
- Over five years, Non Operating Income peaked at $4.2 million in Q3 2023 and troughed at -$24.1 million in Q2 2025.
- A 5-year average of -$688857.1 and a median of $597500.0 in 2022 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2024 and 2025: Non Operating Income jumped 16465.0% in 2024, then slumped 826.68% in 2025.
- Over 5 years, Non Operating Income stood at $721000.0 in 2022, then soared by 280.31% to $2.7 million in 2023, then sank by 132.46% to -$890000.0 in 2024, then surged by 153.26% to $474000.0 in 2025, then sank by 65.19% to $165000.0 in 2026.
- According to Business Quant data, Non Operating Income over the past three periods registered $165000.0, $474000.0, and $387000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | -224.00 Mn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 5.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 41.90 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 10.70 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Incannex Healthcare | 41.37 Mn | 41.37 Mn | - | 165,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 165,000.00 |
| Dec 31, 2025 | 474,000.00 |
| Sep 30, 2025 | 387,000.00 |
| Jun 30, 2025 | -24.08 Mn |
| Mar 31, 2025 | 1.04 Mn |
| Dec 31, 2024 | -890,000.00 |
| Sep 30, 2024 | 834,000.00 |
| Jun 30, 2024 | 3.31 Mn |
| Mar 31, 2024 | 1.38 Mn |
| Dec 31, 2023 | 2.74 Mn |
| Sep 30, 2023 | 4.17 Mn |
| Jun 30, 2023 | 20,000.00 |
| Mar 31, 2023 | 80,000.00 |
| Dec 31, 2022 | 721,000.00 |